PACT 2020 Enterprise Awards Moving to Live Digital Broadcast

‘The show must go on:’ PENN Medicine to be recognized as Digital Innovation Honoree while 27 other companies and individuals will vie for nine competitive awards

Philadelphia, PA., July 9, 2020 – Philadelphia Alliance for Capital and Technologies (PACT) today announced it is pivoting the 2020 Enterprise Awards to a studio-based, live digital broadcast. The one-hour awards program will be held Wednesday, September 9, 2020 starting at 4:30 p.m. EDT and will be free for everyone who registers.

“The Enterprise Awards remain the most competitive and admired business awards in the region. While we all continue to work through challenging times, it’s important that we pause to celebrate the accomplishments of these individuals and companies,” said Dianne Strunk, Vice President at PACT. “This pivot to a live digital broadcast allows us to showcase the vitality and success of our technology and healthcare leaders to a wider audience.”

Additionally, PACT has named PENN Medicine the 2020 Digital Innovation Enterprise Award Honoree. World-renowned for clinical, educational, and research excellence, Penn Medicine is one of the nation’s top academic medical centers.  Its Information Services Department develops and manages technology that supports the day-to-day clinical, research, educational, financial, and management operations. Penn Medicine will be recognized for the creation of its Immune Health Report, a software platform integrating information across its health system to enable real-time clinical decision support and research discoveries in cancer immunotherapy.

The 2020 PACT Enterprise Awards finalists:

Healthcare Innovator (Sponsor: Independence Blue Cross)

Quantitative Radiology Solutions

Spirovant Sciences


Healthcare CEO (Sponsors: EY and Morgan Lewis Bockius)

JeanMarie Markham, Clinlogix

Michael Whitman, Micro Interventional Devices

Tony Coletta, Tandigm Health

Healthcare Emerging (Sponsors: RSM US LLP and SAP)

Camber Spine Technologies


Zynerba Pharmaceuticals

Healthcare Startup (Sponsor: Ben Franklin Technology Partners)

Century Therapeutics

MOBILion Systems


Technology Company (Sponsor: Comcast Business)



InstaMed, a J.P. Morgan Company

Technology CEO (Sponsor: Cozen O’Connor)

Ned Moore, Clutch

John Castleman, Mobiquity

Andy Schwartz, xtraCHEF

Technology Emerging (Sponsors: Fox Rothschild and EisnerAmper)

Benefits Data Trust



Technology Startup (Sponsors: Broadpath and Troutman Pepper)




Investment Deal (Sponsor: Baker Tilly)


Spark Therapeutics

Tmunity Therapeutics


There’s no cost to register for this year’s Enterprise Awards. PACT is accepting contributions to the PACT Foundation, as they work to remove financial barriers to access to PACT membership, mentorship, and programming for entrepreneurs in the region.

Visit the PACT website for additional information. Register for the live digital broadcast of the 2020 PACT Enterprise Awards by clicking here.

About Philadelphia Alliance for Capital and Technologies (PACT) 

PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region.


Media Contact:

Kevin Jurrens


215 644-6504

[email protected]


27th Annual Enterprise Awards

The Enterprise Awards remain the region’s most prestigious business honors for technology and life sciences companies, leaders, and entrepreneurs. Attracting prominent business leaders, the Enterprise Awards gala celebrates achievement, innovation, and success in the Greater Philadelphia region.

Visit the PACT Enterprise Awards website for details, agenda, and more.

Presented By
Fairmount Partners

In Partnership with

Finalists Announced for 2020 Enterprise Awards

Finalists unveiled for nine competitive awards recognizing the achievements of the region’s technology and healthcare leaders and companies

Philadelphia, PA., February 4, 2020 – Philadelphia Alliance for Capital and Technologies (PACT) today announced the 27 finalists competing for one of the nine prestigious awards at the 2020 Enterprise Awards, the region’s most competitive and admired business awards. The gala celebrating the vitality of the region will be held May 12, 2020 at The Kimmel Center for the Performing Arts.

“We are so proud to provide the platform that celebrates our local investors, entrepreneurs and businesses who are leading transformations worldwide in their respective fields,” said Dianne Strunk, Vice President at PACT.  “The judges selected the 27 finalists from a crowded field and it’s my honor to share the results with the region today.”

Introducing the 2020 PACT Enterprise Awards finalists:

Healthcare Innovator (Sponsor: Independence Blue Cross)

Quantitative Radiology Solutions

Spirovant Sciences


Healthcare CEO (Sponsors: EY and Morgan Lewis Bockius)

JeanMarie Markham, Clinlogix

Michael Whitman, Micro Interventional Devices

Tony Coletta,Tandigm Health

Healthcare Emerging (Sponsors: RSM and SAP)

Camber Spine Technologies


Zynerba Pharmaceuticals

Healthcare Startup (Sponsor: Ben Franklin Technology Partners)

Century Therapeutics

MOBiLion Systems


Technology Company (Sponsor: Comcast Business)




Technology CEO (Sponsor: Cozen O’Connor)

Ned Moore, Clutch

John Castleman, Mobiquity

Andy Schwartz, xtraCHEF

Technology Emerging (Sponsors: Fox Rothschild and EisnerAmper)

Benefits Data Trust



Technology Startup (Sponsors: Broadpath and Pepper Hamilton)




Investment Deal (Sponsor: Baker Tilly)


Spark Therapeutics

Tmunity Therapeutics

Tickets for the 2020 PACT Enterprise Awards are currently available.  Visit the PACT website for more information and to register.

About Philadelphia Alliance for Capital and Technologies (PACT) 

PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region.




Media Contact:

Kevin Jurrens


215 644-6504

[email protected]

PACT Recognizes Technology and Healthcare Innovation and Leaders in the Philadelphia Region at the 2019 Enterprise Awards

Philadelphia, PA., May 13, 2019 PACT, the Philadelphia Alliance for Capital and Technologies, celebrated the Philadelphia region’s technology and healthcare innovators and leaders tonight at the 2019 PACT Enterprise Awards. The sold-out event recognized 29 outstanding individuals and organizations through nine competitive categories, as well as the Legend Award Honoree (Howard Ross, LLR Partners) and Digital Innovation Honoree (SEI).

“The Enterprise Awards continues to be the region’s most prestigious business awards program for technology and healthcare companies, leaders and entrepreneurs,” said Dianne Strunk, Vice President, PACT.  “We are so proud to award our local investors, entrepreneurs and businesses who are transforming healthcare, technology and their related fields worldwide.”

Judges sorted through more than 500 award submissions to select the 2019 Enterprise Awards winners:

In addition to the competitive award categories, PACT recognized Howard Ross of LLR Partners as the Legend Award Honoree for his impact on Philadelphia’s entrepreneurial and capital ecosystem throughout his career.  In 1999, Howard co-founded LLR Partners, a middle market private equity firm committed to creating long-term value by growing its portfolio companies.  Howard is currently a member of the Board of Directors of Agility Recovery Solutions, Key2Act, Numotion, Rapid Ratings and Rizing.

PACT also recognized SEI as the Digital Innovation award honoree for the launch of SEI Trade.  The web-based solution digitizes and streamlines the end-to-end processing of investor transactions and onboarding, while facilitating the review, approval, tracking and delivery of subscription documentation and investor data.

About Philadelphia Alliance for Capital and Technologies (PACT)

PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region.  Please visit for more information.


Media Contact:

Kevin Jurrens


(215) 644-6504

[email protected]

Meet the 2019 Enterprise Awards Finalists & Honorees

Please visit to reserve your commemorative tribute journal message. Reserve your tickets for this year’s Gala here.


Bainbridge Health

Bainbridge Health—a spin-out company of The Children’s Hospital of Philadelphia—is on a mission to enhance safety for patients and reduce costs for hospitals by mitigating the risk of medication errors. Bainbridge Health’s proprietary Med O.S.™ technology is a vendor-agnostic Medication Safety Software Platform now in use at both adult and pediatric systems across the country. It serves as an integral component of these systems’ safety and risk management strategies by helping to limit their risk of avoidable medication errors and subsequent costs in an era of changing payer mixes and reimbursement models.

Praeventix (under development)

Praeventix is a biopharmaceutical company focusing on the discovery, development and marketing of novel signal transduction modulating agents for the treatment of Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) and Crohn’s Disease (CD).

Tmunity Therapeutics

Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy to more patients with devastating diseases. Integrating broad collaborations with the University of Pennsylvania (UPenn) and the University of Minnesota with the groundbreaking scientific, clinical and manufacturing expertise and demonstrated track record of its founders, Tmunity is developing personalized immunotherapies for cancer, infectious disease and autoimmune disease that are advancing rapidly toward the clinic.


Augean Robotics

Fully autonomous farming begins with collaborative robots. Augean Robotics is launching a collaborative robotic platform, called Burro, that reduces labor costs for growers of the most labor-intensive crops and paves the way toward the fully autonomous future. Burro follows people, learns the routes and can then rerun them autonomously on its own. Today, Augean Robotics is running paid deployments of Burro with some of the world’s largest growers of specialty crops.


80% of patients that have a behavioral health diagnosis are seen by a primary care provider but never see a behavioral health specialist. 50% of patients that are referred to a specialist never go to their first appointment. NeuroFlow is looking to change this by using AI and machine learning to nudge positive behavior change. NeuroFlow’s digital health platforms promote behavioral healthcare access and engagement in all care settings to improve cost of care, overall wellness and outcomes.


DrayNow is the first real-time Intermodal marketplace, transforming the way freight connects with available Intermodal carriers. The DrayNow Marketplace is accessed by Third-Party Logistics (3PLs), Intermodal Marketing Companies (IMCs), and brokers through a desktop interface where users can view truck capacity in real time, post loads, track load status and obtain electronic documents immediately. With DrayNow’s mobile application, truck drivers can get turnkey access to Intermodal freight, browse loads, compare rates and details, select loads, deliver loads and get paid faster.



Founded in 2014, Allevi’s mission is to make it easy to design and engineer 3D tissues. Its 3D bioprinters and bioinks are used by researchers all around the world to find solutions to humanity’s most difficult problems—to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life.


Tridiuum, Inc., is a digital health company integrating behavioral health into total health. The company’s behavioral health solution accelerates all elements associated with identifying, managing, coordinating and treating behavioral health across the continuum of care. Its cloud-based platform, Tridiuum1, helps to unlock value and profitability by delivering improvements in access, management and outcomes—for patients, providers and health systems.

vybe urgent care

vybe urgent care operates the leading independent network of walk-in urgent care centers in the greater Philadelphia region, with a focus on high-quality medical care and unparalleled patient service. vybe provides a broad range of injury and illness treatments, physical exams and occupational health services. Everyone deserves great care.


AppBus Inc.

The AppBus digital business platform fast-tracks integration to generate end-to-end process automation while enabling secure application delivery to any device. AppBus eXperience Platform combines the power of RPA, API Management and Endpoint Management to seamlessly meet the rising expectations of employees, customers and partners. AppBus leverages existing enterprise assets and enables automation and process transparency, all designed to accelerate the delivery of optimized user experiences.


Guru is the world’s first Revenue Empowerment Network, utilizing AI to make sales, support and customer success teams better at their jobs. Our mission is to reinvent the way teams share and operationalize knowledge. With Guru, the knowledge you need to do your job finds you, when and where you need it most. Guru today serves hundreds of leading enterprises such as Shopify, Square, Spotify, Autodesk and Yext.

Phenom People

Phenom People is redefining what it means to search for a job and recruit top talent. Phenom People is the global leader in Talent Relationship Marketing (TRM), empowering talent acquisition and management teams to discover, engage and retain talent through a single platform approach. The Phenom People platform is built on artificial intelligence (AI), which drives personalization, automation and accuracy for all of the stakeholders in the talent lifecycle. People should be happy and inspired by their job.


EIR Healthcare

EIR Healthcare is a healthcare innovation company focused on bringing efficient industrial practices to the healthcare sector. Its flagship product, MedModular, is a factory-made “hospital room in a box,” pre-fabricated based upon recognized industry best practices and delivered on-site. EIR Healthcare collaborates with each hospital to customize the space for the optimal workflow and patient experience. As the leading innovator of cost-effective, efficient and state-of-the-art healthcare, EIR Healthcare improves quality of care in facilities, allowing for the redistribution of funds from construction to human capital, new research and other core functions. EIR Healthcare is making hospitals more patient-centric and ready for the future.

Micro Interventional Devices, Inc. (MID)

Micro Interventional Devices (MID) is a medical device company that designs, manufactures and commercializes disruptive technologies for use in percutaneous and minimally invasive structural heart repair procedures. Its technology can eliminate the need for open-heart surgery or cardiopulmonary bypass and reduce procedure time and hospital stay and recovery time. While the applications of the technology are expansive, MID focuses on three important unmet needs in structural heart disease: Access and closure, mitral and tricuspid valve repair and mitral valve replacement.

Tandigm Health

Tandigm Health is a population health services organization that partners with over 400 primary care physicians to enhance their ability to provide the finest possible care to the 110,000 patients in its network. By providing meaningful incentives, data and a powerful suite of preventive and chronic care programs, Tandigm Health partners with its physician network to keep patients on a path to health and out of the hospital and ER settings, making healthcare more affordable.


Essential Medical

Essential Medical, Inc., was a privately held medical device company that developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies. Complex vascular procedures such as aortic valve replacement and aortic aneurysm repair are moving toward minimally invasive approaches, but traditional approaches to vascular closure at the end of the procedure often caused complications and led to costly and prolonged hospitalization. In its CE Mark study, the MANTA Device demonstrated rapid and reliable hemostasis with its resorbable collagen-based technology and complication rates that were non-inferior to surgical and suture-based closure methods.

Essential Medical was acquired by Teleflex Incorporated in October 2018. While physician adoption of the MANTA Device in international markets has been impressive, with over 8,000 procedures completed across a number of countries in the EU, Essential Medical felt an outside partner, with established sales and marketing channels, was needed to help MANTA reach its full market potential. Teleflex’s strong presence in the interventional cardiology market made it an ideal partner to accelerate adoption and growth of this breakthrough technology worldwide.


LiquidHub was a customer engagement company that partnered with businesses to improve customer experience and drive growth. LiquidHub was founded in 2001 as a technology solutions business, providing deep technology integration expertise. Over 17 years, LiquidHub expanded from a local IT company to a global customer engagement agency. From 2011 to 2016, the company quickly expanded, quadrupling in size. During this growth period, the company acquired multiple companies with varying areas of expertise, including analytics, digital marketing, industrial and digital design, cognitive science and cloud services. Its organic growth and smart acquisitions enabled LiquidHub to continue growing each year. In February 2018, Capgemini, a global leader in consulting and technology, acquired LiquidHub for $496 million. Through the acquisition, Capgemini reinforced its digital consulting capabilities and accelerated its portfolio shift in North America.


Velicept is a clinical-stage development company founded in 2015 to develop solabegron, a highly differentiated next-generation beta-3 agonist for the treatment of overactive bladder (OAB). The company has developed a proprietary formulation that incorporates the intrinsic properties of solabegron to create an optimized best-in-class product. A strong IP estate protects both the molecule and the formulation out through 2036. Solabegron has the potential to disrupt the $4 billion OAB market with a next-generation agent offering improved relief of symptoms for OAB patients. In 2018, Velicept raised approximately $23.5 million of equity and closed a $15 million debt facility. The capital is being used to fund two large Phase 2 dose ranging studies and ongoing Phase 3 work to create the most time-efficient path to market.



SEI is a leading global provider of outsourced asset management, investment processing, and investment operations solutions that help corporations, financial institutions, financial advisors and affluent families create and manage wealth.

SEI Trade is a web-based solution that digitizes and streamlines the end-to-end processing of investor transactions and onboarding, while facilitating the review, approval, tracking and delivery of subscription documentation and investor data:

  • Transforms any form into digital, guided, wizard-based experience.
  • APIs automate the pre-fill of forms from existing data sources.
  • Configurable conditions/business rules validate data and ensure that processes are completed in good order with messaging and alerts to assist end users.
  • Customizable workflows can be designed to digitize the entire business process with various review assignments and data integration points to allow for straight-thru processing.



Accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. Connecting the widest array of personal health data and programs, Accolade presents a single point of contact to the most effective health and benefits resources, while coordinating with providers at every step. Combining technology and human expertise in new ways, Accolade is changing how employees and their family members access and use the employee healthcare and benefits programs they need to live healthier, happier and more productive lives.

Frontline Education

Frontline Education provides human capital management for K-12 education, serving over 12,000 educational organizations, 80,000 schools, and millions of educators, administrators and support personnel. Bringing together people, programs and processes from 12 companies since 2014, Frontline has built the first fully integrated human capital management platform for the K-12 market.


InstaMed powers a better healthcare payments experience through one platform that connects consumers, providers and payers for every healthcare payment transaction. InstaMed’s patented technology seamlessly drives electronic transactions, securely moving money and related healthcare data to the benefit of all those involved in the healthcare payment ecosystem.  


Clutch, Ned Moore, CEO

Founded in 2012, Clutch has revolutionized how marketing teams for premier brands develop and foster relationships with their customers. Its advanced marketing platform serves as a customer hub, delivering deep intelligence derived from real-time behaviors and transactions across in-store, online, mobile and social channels.

Ned Moore is one of the key visionaries behind Clutch, helping identify the tremendous gap in how business-to-consumer (B2C) companies manage and leverage their existing customers. Moore’s management philosophy was shaped by mentors who helped him understand that successfully growing a business depends on attracting the right people to an organization and then empowering them to succeed themselves.

Dell Boomi, Chris McNabb, CEO

Dell Boomi, an independent business unit of Dell, brings far greater organizational speed and agility to any business. The Boomi integration platform as a service (iPaaS) dramatically transforms the way an organization can connect, create, manage and govern its applications and data. Since Dell acquired Boomi in November 2010, Boomi has become the fastest-growing acquisition in Dell’s history, as it helps businesses from around the world and across industries address their most daunting integration challenges.

Chris McNabb is the Chief Executive Officer of Dell Boomi, where he is responsible for all operations and strategic direction. Chris brings more than 20 years of software development and line of business experience from a diverse set of prior roles. Under Chris’ leadership, Dell Boomi met an aggressive and impressive five-year revenue goal in only three years. Boomi has grown from 4,800 to more than 7,500 customers, and the number of employees has increased from 500 to 800+ globally, with expanded operations throughout the EMEA and APJ regions. During this high-growth period, Chris has been fiercely protective of the company’s corporate culture.

Sidecar, Andre Golsorkhi, CEO

Sidecar is a technology company dedicated to retail. Its mission is to maximize the value of performance marketing. By combining deep data, knowledgeable humans and inspired technology, Sidecar is the magic behind retail’s smartest marketing campaigns.

Andre Golsorkhi is a technology entrepreneur with a history of creating organizations that help advance the digital transformation of retail. His most recent venture is Sidecar, a technology company based in Philadelphia. Under Golsorkhi’s guidance as CEO, Sidecar continues to grow quickly to meet customer needs—tripling staff over the past three years and securing $24 million in financing to date. Golsorkhi previously founded Omeda, a development firm specializing in emerging web technologies, and MediLync, a mobile patient accounting software for healthcare professionals.


BioTelemetry, Joseph H. Capper, President and CEO

BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. It provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers.

Joseph Capper has been President and Chief Executive Officer of BioTelemetry since 2010. Prior to joining BioTelemetry, Capper served as President, Chief Executive Officer and a member of the board of directors of Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer and marketer of diabetes management products, which he joined in 2009. Prior to joining Home Diagnostics, from 2002 to 2009, he was President and Chief Executive Officer of CCS Medical Inc., a private company that is a leading provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories.

Galera Therapeutics, J. Mel Sorensen, M.D., President and CEO

Galera Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing novel therapeutics targeting oxygen metabolic pathways with the potential to transform how radiation therapy is used in patients with cancer. The FDA has granted Fast Track and Breakthrough Therapy designations to avasopasem manganese, Galera’s lead product candidate. In September 2018, Galera announced a financing of $150 million, which permits the company to advance avasopasem manganese through Phase 3 and to New Drug Application submission.

Galera’s success is inextricably linked with Dr. J. Mel Sorensen’s leadership. Dr. Sorensen took the helm of Galera upon its founding in 2012. His experiences as a physician, a researcher and in clinical development have helped him lead a small, research-focused company. His previous experience with raising over $300 million in private financing rounds and licensing deals paved the way for Galera’s successful fundraises ($11 million, $57 million and $150 million) to propel the company forward on its path toward revolutionizing radiotherapy in cancer treatment.

Nevakar, Navneet Puri, CEO

Nevakar is a fully integrated specialty pharmaceutical company, focused on developing innovative ophthalmic and injectable products. Nevakar’s business model is built around drug repositioning and repurposing. These drug repositioning efforts are focused on studying new therapeutic indication of existing molecules; developing novel or superior formulations; designing improved, safer and more functional packaging; and implementing effective regulatory and clinical strategies that support new uses or indications.

Nevakar was founded in 2015 by Dr. Navneet Puri, a successful scientist and entrepreneur. His vision is to establish a sustainable and scalable novel product differentiation approach targeted to address unmet clinical and commercial needs for established molecules. After forming the company and establishing its unique business model, Dr. Puri focused on building an experienced team. He remains deeply engaged in portfolio strategy and selection and played a major role in a series of fundraises for the company (a total of $120M in three years).

Legend Honoree

Howard Ross
LLR Partners

Howard Ross co-founded LLR Partners in 1999. LLR Partners is a middle market private equity firm committed to creating long-term value by growing its portfolio companies. The firm invests primarily in software, healthcare, education, security and fintech businesses. With more than $3.5 billion raised across five funds, LLR is a flexible provider of capital for growth, recapitalizations and buyouts.

Howard is currently a member of the Board of Directors of Agility Recovery Solutions, Key2Act,
Numotion, Rapid Ratings and Rizing. He has also served on the boards of Alsbridge, BrightHeart Veterinary Centers, eResearch Technology, excelleRx, Five Below, Gestalt, InnaPhase, Iron Mountain, Maxwell Systems, Medmark, Pet360, SDI Health, SEI Investments, Singer Equities, Taratec and UltiSat.

Prior to forming LLR, Howard was the partner in charge of Arthur Andersen’s Growth Company Practice in the Greater Philadelphia market. In his 26 years at Arthur Andersen, he built a practice of over 80 people, including five partners, serving over 175 rapidly growing companies.

Howard holds a B.S. in Economics from the Wharton School of the University of Pennsylvania, graduating summa cum laude. Howard and his wife, Susan, live in Bryn Mawr, PA with their two dogs. Their two children, Matt and Rachael, are in their 30s and live in Manhattan and Chapel Hill.


2020 Enterprise Awards Finalists

  • Healthcare Innovator
    • Quantitative Radiology Solutions
    • Spirovant Sciences
    • Tridiuum

Sponsor:  Independence Blue Cross

  • Healthcare CEO
    • JeanMarie Markham, Clinlogix
    • Michael Whitman, Micro Interventional Devices
    • Tony Coletta,Tandigm Health

Sponsors:  EY and Morgan Lewis

  • Healthcare Emerging
    • Camber Spine Technologies
    • Imalogix
    • Zynerba Pharmaceuticals

Sponsors:  RSM US LLP and SAP

  • Healthcare Startup
    • Century Therapeutics
    • MOBILion Systems
    • Quil

Sponsor:  Ben Franklin Technology Partners

  • Technology Company
    • Accolade
    • Elemica
    • InstaMed, a J.P. Morgan Company

Sponsor:  Comcast Business

  • Technology CEO
    • Ned Moore, Clutch
    • John Castleman, Mobiquity
    • Andy Schwartz, xtraCHEF

Sponsor:  Cozen O’Connor

  • Technology Emerging
    • Benefits Data Trust
    • Greenphire
    • Perpay

Sponsors:  Fox Rothschild LLP and EisnerAmper

  • Technology Startup
    • Cesium
    • ForMotiv
    • ZeroEyes

Sponsors:  Broadpath and Troutman Pepper

  • Investment Deal
    • iPipeline
    • Spark Therapeutics
    • Tmunity Therapeutics

Sponsors:  Baker Tilly


2020 Enterprise Awards Judges

Judging Partner – KPMG LLP

Presiding Judge – Technology: Andrew Cherry, Partner, KPMG LLP

Presiding Judge – Healthcare: Jennifer Strong, Partner, KPMG LLP

Lead Judge: Rick Riegel, Vice Chairman, Phlexglobal, Inc.

Technology Judges

  • Amy Loftus
    General Manager
  • April Walker 
    Microsoft Technology Center – Philadelphia 
  • Ben Thrift
    Director of Engineering 
    Boomi, a Dell Technologies Business 
  • Brian Kim
    NewSpring Capital
  • Brian Knotts 
    Senior Vice President, Applied Research
  • John Viglione
    Executive Vice President
  • Larry Berran
  • Matt Klinger
    Senior Vice President, Market Manager
  • Nassar Nizami
    Chief Information Officer
    Jefferson University/Einstein
  • Sean Dowling 
    Osage Partners
  • William Marvin
    Chief Executive Officer

Healthcare Judges

  • Calvin Knowlton
    Chief Executive Officer
    Tabula Rasa
  • Gerianne DiPiano
    Chief Executive Officer
  • Greg Cathcart
    Chief Executive Officer
    Excellis Health Solutions, LLC
  • John Younger, MD
    Vice President, Science & Technology
    University City Science Center 
  • Kamna Giare-Patel
    Senior Director, Global Continuation Engineering – Innovation Department
    DSM Biomedical 
  • Katherine High
    Spark Therapeutics
  • Kevin Brophy
    Life Sciences Industry Principal
  • Michelle Histand
    Director, Corporate Development and Innovation
    Independence Blue Cross
  • Scott Perricelli
    Partner, Healthcare Investments
  • Vanessa Chan 
    Professor of Practice, Innovation and Entrepreneur
    Center for Technology Transfer
    University of Pennsylvania 
  • Zev Sunleaf
    Vice President, Office of Technology Transfer, Commercialization & Innovation
    Children’s Hospital of Philadelphia

Celebrate Our Innovators!

September 9, 2020

Live Digital Broadcast
4:30 – 5:30 p.m.

Tribute Journal

A digital Tribute Journal will be available to all guests of the Enterprise Awards. The Tribute Journal is an ideal opportunity to recognize our honorees and finalists at the Enterprise Awards by honoring them in the context of a memorable message.

2019 Tribute Journal (PDF)


This year the Enterprise Awards will be broadcast LIVE! to your home, office, or wherever you choose to tune in. Our in-studio hosts will guide our community through this annual celebration of achievement, innovation, and success in the Greater Philadelphia region.

Penn Medicine Name Digital Innovation Honoree

World-renowned for clinical, educational, and research excellence, Penn Medicine is one of the nation’s top academic medical centers. Our Information Services Department develops and manages technology that supports the day-to-day clinical, research, educational, financial, and management operations of five hospitals, several satellite practices, and more than 5,000 physicians. The Penn Metabolic and Bariatric Surgery Program offers complete surgical, nursing, nutrition, and psychological care for people with severe obesity.

We are trying to help patients with significant obesity lose weight through bariatric surgery, which reduces the size of the stomach and is the most effective and durable treatment for severe obesity. Today, 37.7 percent of US adults have obesity (while another one-third are overweight). Obesity is linked to heart disease, stroke, type 2 diabetes, and some types of cancer. Estimated annual obesity-related health care costs (excluding employment-related and social costs) in the US are $190.2 billion—almost 21 percent of annual medical spending. While 16 million US adults are candidates for bariatric surgery, only one percent receive the treatment—with the complexity and overwhelming nature of the preoperative process serving as the primary barrier. In addition to extensive pre-op testing, this process includes up to six months of supervised weight loss (required by most insurance companies) and certain lifelong post-op food restrictions.

Health care apps are based on the well-documented finding that patients want to be engaged in their own care. While most commercially available health apps are primarily directed at patients, Penn Life Gained, the Penn Medicine bariatric surgery app, early adoption technology launched in October of this year, is aimed at both patients and care-providers Additionally, patients use social media to share experiences with other patients, The app will generate more efficient care as a result of connecting the physician and patient to the care plan. It builds on and extends the benefits of Apple CareKit, an open-source software framework that allows developers to create apps for helping patients manage their medical conditions. Through the CareKit side of the Penn app, our patients: 1) receive pre- and post-op instructions and meal-time and supplement reminders; 2) monitor food intake, calorie count, and nutrition content; 3) set and track progress on personal goals; 4) gain access to online resources such as weight-loss support groups and recipes for healthy meals; 5) check their daily step counts and expended calories; 6) identify and report symptoms; and more, all with the goal of a better surgical outcome and sustained, life-long weight loss. In contrast to the few existing bariatric apps, our Penn-physician-designed adaptation includes a unique clinician facing app that enables doctors, nurses, and dietitians to supply targeted, individualized care, making adjustments as needed in response to real-time patient data and information. Through this clinician app, care-providers gain pre-op access to patients’ caloric intake, food choices, activity levels, and more in one convenient dashboard and communicate feedback and recommendations back to the patient—ideal for managing care and maintaining momentum between office visits. Post-op, clinicians can track patient progress, e.g., caloric and activity levels, vitamin and supplement adherence, and respond to episodes of pain, nausea, vomiting, problems at incision sites, and other symptoms reported by patients. (This information can also be incorporated into decision-support software for bariatric surgeons.) A key feature allows clinicians to customize the app, e.g., removing the post-op goal of daily weighing if a patient has a history of bulimia. Feedback from users and potential users has been positive: “I call and tell them that information all the time, so … there’s less I need to look up and tell them.” “I just like it that there’s someone else watching me.” “Knowing that Penn is behind [the app] … would make me feel comfortable using it.”

Since there are many commonalities in patients’ pre- and post-op surgical requirements, there is enormous market potential for our app, essentially encompassing every form of surgery as well as numerous long-term health care problems such as cancer, diabetes, and cardiovascular disease. Additionally, Penn has entered into a contract with Independence Blue Cross, in which Penn will not seek reimbursement for hospital readmissions within 30 days after inpatient stay or surgery. By alerting physicians to patient hurdles and complications in real time and enabling timely interventions, the app may reduce 30-day, non-reimbursable readmissions. And by actively engaging patients with their caregivers in the demanding pre-op process described above, we expect to reduce the attrition rate and more successfully lead patients to having the surgery. Finally, bariatric surgery provides overall health care cost savings within two-four years of the procedure, reducing expenses for patients, insurers, and businesses that pay for their employees’ health insurance.

This blended patient/provider app is Penn-owned and Penn-developed, compelling features in light of Penn’s international reputation for health care excellence. Penn Metabolic and Bariatric Surgery, which developed the physician-side of the app in conjunction with Penn Medicine’s Information Services Department, is the highest volume and most experienced bariatric surgery practice in the Philadelphia area.

Michael DiPiano to be Named Legend Award Honoree for Lifetime Achievement at 2018 PACT Enterprise Awards

PACT Also Reveals Finalists for 25th Annual Enterprise Awards

Philadelphia, February 2, 2018 – Philadelphia Alliance for Capital and Technologies (PACT) announced today Michael DiPiano, Managing General Partner and Co-Founder, NewSpring Capital, will be recognized as the 2018 Legend Award Honoree for Lifetime Achievement at the 2018 Enterprise Awards. PACT presents the Legend Award each year to an individual who has forwarded technology and science in the region through leadership and exemplary work.  Additionally, PACT revealed the finalists for each of the nine competitive award categories.  The formal presentation will take place at the 25th Annual Enterprise Awards black-tie gala on Wednesday, May 9, 2018 at The Kimmel Center.

“Through his leadership and outstanding work, Mike DiPiano has made an indelible mark on our community, said Dean Miller, President & CEO of PACT.  “He has passionately championed numerous successes both as a serial entrepreneur and investor.  In NewSpring, Mike has built one of the most successful firms in the country spanning four strategies with $2B in assets under management.  We congratulate Mike as our Legend Award Honoree for his lifetime achievements and for his many successes yet to come.”

DiPiano is Managing General Partner and co-founder of NewSpring and a General Partner of the Firm’s dedicated growth equity funds.  He serves as a member of the investment committee of all NewSpring funds.  Before co-founding NewSpring in 2001, DiPiano was a serial entrepreneur and investor.  He has led or co-led investment into companies in the business services, healthcare and information technology industries.  Prior to co-founding NewSpring, he was affiliated with Safeguard Scientifics Inc. (NYSE:SFG) and was a division CEO and Director of Chemical Leaman Corporation.  DiPiano began his career with Baxter Healthcare Corporation (NYSE:BAX) holding numerous positions there, culminating as Vice President responsible for Operations and Sales of the Industrial Scientific Products Division.

This year, nearly five hundred applications were received from technology and healthcare companies competing for one of nine awards.  This year’s finalists are:


Healthcare Innovator

Amicus Therapeutics

OraSure Technologies

Spark Therapeutics


Healthcare CEO

Adaptimmune, James Noble

Frontage Laboratories, Song Li

Pentec Health, Joseph Cosgrove


Healthcare Emerging

ACI Clinical




Healthcare Startup

LIA Diagnostics

Mebias Discovery

Talee Bio



Technology Company

Analytical Graphics


Dell Boomi


Technology CEO

Clutch, Ned Moore

EPAM, Arkadiy Dobkin

Turn5, Steve Voudouris


Technology Emerging


Relay Network



Technology Startup

Layer 8 Security




Investment Deal


Frontline Education

Marinus Pharmaceuticals



“With hundreds of nominations, our judges were truly challenged and did a terrific job identifying honorees that represent the best of our region’s proud technology and life sciences communities,” said Dianne Strunk, Vice President of PACT.  “They truly represent the mission of the Enterprise Awards by showcasing growth, hard work, and excellence in our silver anniversary year.  Thank you to all of the companies that submitted, and on behalf of PACT and Enterprise Award Judging Partner KPMG, I congratulate all of this year’s Finalists.”

PACT will present a commemorative Tribute Journal to all guests of the 2018 Enterprise Awards. The Tribute Journal is an ideal opportunity to recognize Mike DiPiano and the finalists at the Enterprise Awards by honoring them with a memorable message. Guests may reserve their message by Thursday, March 6, 2018.

Tickets for the 2018 Enterprise Awards are currently available.  Visit the PACT website for information and registration.

For more information about the 2018 Enterprise Awards visit

About Philadelphia Alliance for Capital and Technologies (PACT)
PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region.


Media Contact:

Kevin Jurrens

(215) 644-6504

[email protected]

# # #